Evidence map›Paper›PMID 26833182›Full record

SynthesisScientific reports2016

Genome-Wide Meta-Analysis of Cotinine Levels in Cigarette Smokers Identifies Locus at 4q13.2.

Jennifer J Ware, Xiangning Chen, Jacqueline Vink, Anu Loukola, Camelia Minica, Rene Pool, Yuri Milaneschi, Massimo Mangino, Cristina Menni, Jingchun Chen and 28 more

Open access · goldAbstract readMeta-AnalysisTwin Study
In one paragraph

Synthesis in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 4 pooled it
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 4 syntheses or guidelines pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Review
  7. Article
  8. Review
  9. Article
  10. Multi-Polygenic Analysis of Nicotine Dependence in Individuals of European Ancestry.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2021
    Article
  11. Article
  12. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2020
    Article
  13. Polygenic Risk Scores for Subtyping of Schizophrenia.Schizophrenia research and treatment · 2020
    Article
  14. Translational Molecular Approaches in Substance Abuse Research.Handbook of experimental pharmacology · 2020
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Prediction of Schizophrenia Diagnosis by Integration of Genetically Correlated Conditions and Traits.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors at 15 institutions in 6 countries.

Jennifer J WareMRC Integrative Epidemiology Unit (IEU) at the University of Bristol, Bristol, BS8 2BN, United Kingdom.
Xiangning ChenVirginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, VA 23298, United States.
Jacqueline VinkDepartment of Biological Psychology, VU University, Amsterdam, 1081 BT, Netherlands.
Anu LoukolaDepartment of Public Health, University of Helsinki, Helsinki, FI-00014, Finland.
Camelia MinicaDepartment of Biological Psychology, VU University, Amsterdam, 1081 BT, Netherlands.
Rene PoolDepartment of Biological Psychology, VU University, Amsterdam, 1081 BT, Netherlands.
Yuri MilaneschiDepartment of Psychiatry and EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, 1081 HL, Netherlands.
Massimo ManginoDepartment of Twin Research and Genetic Epidemiology, King's College London, London, SE1 7EH, United Kingdom.
Cristina MenniDepartment of Twin Research and Genetic Epidemiology, King's College London, London, SE1 7EH, United Kingdom.
Jingchun ChenVirginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, VA 23298, United States.
Roseann E PetersonVirginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, VA 23298, United States.
Kirsi AuroNational Institute for Health and Welfare, Helsinki, FI-00271, Finland.
Leo-Pekka LyytikäinenDepartment of Clinical Chemistry, Fimlab Laboratories, Tampere, FI-33520, Finland.
Juho WedenojaDepartment of Public Health, University of Helsinki, Helsinki, FI-00014, Finland.
Alexander I StibySchool of Social and Community Medicine, University of Bristol, Bristol, BS8 2BN, United Kingdom.
Gibran HemaniMRC Integrative Epidemiology Unit (IEU) at the University of Bristol, Bristol, BS8 2BN, United Kingdom.
Gonneke WillemsenDepartment of Biological Psychology, VU University, Amsterdam, 1081 BT, Netherlands.
Jouke Jan HottengaDepartment of Biological Psychology, VU University, Amsterdam, 1081 BT, Netherlands.
Tellervo KorhonenDepartment of Public Health, University of Helsinki, Helsinki, FI-00014, Finland.
Markku HeliövaaraNational Institute for Health and Welfare, Helsinki, FI-00271, Finland.
Markus PerolaNational Institute for Health and Welfare, Helsinki, FI-00271, Finland.
Richard J RoseDepartment of Psychological and Brain Sciences, Indiana University, Bloomington, IN 47405, United States.
Lavinia PaternosterMRC Integrative Epidemiology Unit (IEU) at the University of Bristol, Bristol, BS8 2BN, United Kingdom.
Nic TimpsonMRC Integrative Epidemiology Unit (IEU) at the University of Bristol, Bristol, BS8 2BN, United Kingdom.
Catherine A WassenaarDepartment of Pharmacology and Toxicology, University of Toronto, Toronto, M5S 1A8, Canada.
Andy Z X ZhuDepartment of Pharmacology and Toxicology, University of Toronto, Toronto, M5S 1A8, Canada.
George Davey SmithMRC Integrative Epidemiology Unit (IEU) at the University of Bristol, Bristol, BS8 2BN, United Kingdom.
Olli T RaitakariDepartment of Clinical Physiology and Nuclear Medicine, Turku University Hospital, Turku, FI-20521, Finland.
Terho LehtimäkiDepartment of Clinical Chemistry, Fimlab Laboratories, Tampere, FI-33520, Finland.
Mika KähönenDepartment of Clinical Physiology, Tampere University Hospital, Tampere, FI-33521, Finland.
Seppo KoskinenNational Institute for Health and Welfare, Helsinki, FI-00271, Finland.
Timothy SpectorDepartment of Twin Research and Genetic Epidemiology, King's College London, London, SE1 7EH, United Kingdom.
Brenda W J H PenninxDepartment of Psychiatry and EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, 1081 HL, Netherlands.
Veikko SalomaaNational Institute for Health and Welfare, Helsinki, FI-00271, Finland.
Dorret I BoomsmaDepartment of Biological Psychology, VU University, Amsterdam, 1081 BT, Netherlands.
Rachel F TyndaleDepartment of Pharmacology and Toxicology, University of Toronto, Toronto, M5S 1A8, Canada.
Jaakko KaprioDepartment of Public Health, University of Helsinki, Helsinki, FI-00014, Finland.
Marcus R MunafòMRC Integrative Epidemiology Unit (IEU) at the University of Bristol, Bristol, BS8 2BN, United Kingdom.
University of Bristol · GBVrije Universiteit Amsterdam · NLFinnish Institute for Health and Welfare · FIKing's College London · GBUniversity of Helsinki · FIVirginia Commonwealth University · USEMGO Institute for Health and Care Research · NLFimlab (Finland) · FIInstitute for Molecular Medicine Finland · FIUniversity of Toronto · CACentre for Addiction and Mental Health · CAIndiana University Bloomington · USTampere University · FITurku University Hospital · FIUniversity of Tartu · EE

Funding

University of Toronto Coordinating Genetics Core & Clinical Trial SiteU01DA020830 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI CONTI, DAVID V · 2005 to 2014
$22.4M
Research Training: Psychiatric &Statistical GeneticsT32MH020030 · NIMH · VIRGINIA COMMONWEALTH UNIVERSITY · PI HERMINE H MAES, MICHAEL CHURTON NEALE · 1999 to 2026
$6.7M
Research Education in Statistical Genetics of Substance AbuseR25DA026119 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI NEALE, MICHAEL CHURTON · 2008 to 2018
$3.2M
ADOLESCENT ALCOHOL ABUSE: A TWIN-STUDY PERSPECTIVER37AA012502 · NIAAA · TRUSTEES OF INDIANA UNIVERSITY · PI ROSE, RICHARD JOSEPH · 2000 to 2009
$2.9M
Psychometric and Genetic Assessments of Substance UseR01DA018673 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI NEALE, MICHAEL CHURTON · 2004 to 2019
$2.3M
Genes and molecular pathways in nicotine dependence and withdrawalR01DA032246 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI DAMAJ, M. IMAD, MILES, MICHAEL F · 2013 to 2017
$1.7M
Adolescent Alcohol Abuse: A Twin-Study PerspectiveR01AA012502 · NIAAA · TRUSTEES OF INDIANA UNIVERSITY · PI ROSE, RICHARD JOSEPH · 2013 to 2017
$1.2M
British Heart FoundationCancer Research UKCIHR TMH109787Department of HealthEuropean Research Council 284167Medical Research Council G9815508Medical Research Council MC_PC_15018Medical Research Council MC_UU_12013/1Medical Research Council MC_UU_12013/3Medical Research Council MC_UU_12013/6Medical Research Council MR/J012165/1Medical Research Council MR/K023195/1NIAAA NIH HHS AA-12502NIDA NIH HHS DA020830NIDA NIH HHS R01 DA018673NIDA NIH HHS R01DA032246NIDA NIH HHS R25 DA26119NIMH NIH HHS T32 MH020030NIMH NIH HHS T32 MH20030Wellcome Trust 202802/Z/16/ZWellcome Trust WT083431MA
6 · The paper itself

Abstract

Genome-wide association studies (GWAS) of complex behavioural phenotypes such as cigarette smoking typically employ self-report phenotypes. However, precise biomarker phenotypes may afford greater statistical power and identify novel variants. Here we report the results of a GWAS meta-analysis of levels of cotinine, the primary metabolite of nicotine, in 4,548 daily smokers of European ancestry. We identified a locus close to UGT2B10 at 4q13.2 (minimum p = 5.89 × 10(-10) for rs114612145), which was consequently replicated. This variant is in high linkage disequilibrium with a known functional variant in the UGT2B10 gene which is associated with reduced nicotine and cotinine glucuronidation activity, but intriguingly is not associated with nicotine intake. Additionally, we observed association between multiple variants within the 15q25.1 region and cotinine levels, all located within the CHRNA5-A3-B4 gene cluster or adjacent genes, consistent with previous much larger GWAS using self-report measures of smoking quantity. These results clearly illustrate the increase in power afforded by using precise biomarker measures in GWAS. Perhaps more importantly however, they also highlight that biomarkers do not always mark the phenotype of interest. The use of metabolite data as a proxy for environmental exposures should be carefully considered in the context of individual differences in metabolic pathways.

Indexed as

CotinineGenetic LociLinkage DisequilibriumChromosomes, Human, Pair 4FemaleGenome-Wide Association StudyGlucuronosyltransferaseHumansMaleSmokingCotinineGlucuronosyltransferaseUGT2B10 protein, human

Identifiers

PMID26833182
PMCPMC4735517
OpenAlexW2297987520

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.